# Darifenacin

NDC: 52605-067
Generic name: Darifenacin Hydrobromide
Labeler / Manufacturer: POLYGEN PHARMACEUTICALS INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20201201

FDA application: ANDA211045

## Active ingredients

- DARIFENACIN HYDROBROMIDE: 7.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"52605-067"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=52605-067
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=62a72d3e-3c33-4f2d-b3d0-2e014f704c63